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Abstract
Implantable cardiac pacemakers restore normal heart rhythm by delivering external electrical pacing to the
heart. The pacemaker software is life-critical as the timing of the pulses determine its ability to control the
heart rate. Recalls due to software issues have been on the rise with the increasing complexity of pacing
algorithms. Open-loop testing remains the primary approach to evaluate the safety of pacemaker software.
While this tests how the pacemaker responds to stimulus, it cannot reveal pacemaker malfunctions which
drive the heart into an unsafe state over multiple cycles. To evaluate the safety and efficacy of pacemaker
software we have developed a heart model to generate different heart conditions and interact with real
pacemakers. In this paper, we introduce the closed-loop testing platform which consists of a programmable
hardware implementation of the heart that can interact with a commercial pacemaker in closed-loop. The
heart-on-a-chip implementation is automatically generated from the Virtual Heart Model in Simulink which
models different heart conditions. We describe a case study of Endless Loop Tachycardia to demonstrate
potential closed-loop pacemaker malfunctions which inappropriately increase the heart rate. The test platform
is part of our model-based design framework for verification and testing of medical devices with the patient--
in-the-loop.
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Abstract—Implantable cardiac pacemakers restore normal
heart rhythm by delivering external electrical pacing to the
heart. The pacemaker software is life-critical as the timing of
the pulses determine its ability to control the heart rate. Recalls
due to software issues have been on the rise with the increasing
complexity of pacing algorithms. Open-loop testing remains the
primary approach to evaluate the safety of pacemaker software.
While this tests how the pacemaker responds to stimulus, it
cannot reveal pacemaker malfunctions which drive the heart
into an unsafe state over multiple cycles. To evaluate the safety
and efficacy of pacemaker software we have developed a heart
model to generate different heart conditions and interact with
real pacemakers. In this paper, we introduce the closed-loop
testing platform which consists of a programmable hardware
implementation of the heart that can interact with a commercial
pacemaker in closed-loop. The heart-on-a-chip implementation
is automatically generated from the Virtual Heart Model in
Simulink which models different heart conditions. We describe
a case study of Endless Loop Tachycardia to demonstrate poten-
tial closed-loop pacemaker malfunctions which inappropriately
increase the heart rate. The test platform is part of our model-
based design framework for verification and testing of medical
devices with the patient–in-the-loop. 1
I.. INTRODUCTION
The Electrical Conduction System of the heart coordinates
the contraction of heart muscles for efficient blood circulation
within our body. Derangements in the rhythm of generation
and conduction of electrical signals within the heart tissue
result in abnormal heart rhythm, which is referred to as
an arrhythmia. Rhythm management devices, such as the
implantable cardiac pacemaker, are designed to sense electrical
activity of the heart, diagnose the current heart condition, and
deliver artificial pacing therapies to maintain appropriate heart
rhythm. The direct interaction between the pacemaker and the
heart makes the closed-loop system a perfect example of a
Cyber-Physical System and the safety of the device operation
is life-critical.
During the past decade decade, over 600,000 cardiac
devices were recalled due to flaws which caused adverse
health consequences or death [1]. With increasing complex-
ity of device software, recalls are due to software-related
malfunctions [2] have been rising. While the US Food and
Drug Administration (FDA) require device manufacturers to
establish the safety and efficacy of their devices, they do not
explicitly specify the methods to verify the device software
design or analyze the code [3].
1This research work was supported in part by the NSF CAREER 1253842
NSF CPS-0931239 and MRI-0923518 grants.
Platform testing remains the primary means to verify and
validate device software. Currently testing is done by feeding
recorded open-loop heart signals to the device and evaluating
the device output. However, the change in the state of the
heart condition, in response to device output, is not taken into
account. Thus, device malfunctions involving state changes due
to multiple closed-loop interactions will not be captured during
testing.
The heart-on-a-chip platform Fig. 1 utilizes the model-
based framework for developing safe device software proposed
in [4]. The outline of the framework is shown in Fig. 2; at
verification level, the safety of the Boston Scientific pacemaker
specification is first evaluated by verifying the abstract model
of the algorithms in the UPPAAL model checker [5]. The ver-
ified model of the pacemaker is then automatically translated
into Stateflow/Simulink using the UPP2SF tool [4]. At the
simulation level, safety violations from verification level, as
well as other non-timing aspects of the pacemaker are checked
against more detailed heart model. Using the Simulink Coder,
the Stateflow model of the pacemaker is translated into C code.
At testing level, hardware-related aspects (Scheduling delays,
electrical interference, etc.) of the pacemaker can be evaluated.
This end-to-end tool chain guarantees the verified properties
are preserved during model translation and code generation
which can save significant debugging time.
At each level of the tool chain, it is important to have a
model of the heart which is able to represent different heart
Heart on FPGA
Boston Scientific
Pacemaker
Analog Interface
Fig. 1. The heart-on-a-chip testing platform consists of a heart
implementation on an programmable chip (FPGA) and an analog
interface for signal isolation and attenuation to interface with a
pacemaker. In this figure, the platform is testing a Boston Scientific
pacemaker.
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Fig. 2. Model-based framework for pacemaker software development.
Abstract model of the pacemaker software is first verified in model
checker UPPAAL and translated into Stateflow model. Through a
rigorous model translation and code generation tool-chain the verified
pacemaker model is implemented as C code. At each level, a model
of the heart is interacting with the pacemaker model in closed-loop
conditions and responds to device outputs. The model should
be implemented in hardware to interact with both white-box
and black-box (commercial) pacemaker implementations. To
this effect, Jiang et. al developed the Virtual Heart Model
(VHM) to model the electrical conduction system of the heart
[6]. The goal of this effort is to demonstrate the interaction of
this heart model on a programmable hardware platform with a
commercial pacemaker, and illustrate the importance of closed-
loop testing with a clinically relevant case-study.
The remainder of the paper is organized as follows: Section
2 introduces the Virtual Heart Model (VHM) and its Simulink
implementation. Section 3 describes how the simulink model
is automatically translated into Verilog code using Simulink
Hardware Description Language (HDL) Coder [7] and op-
erated on a Field Programmable Gate Array (FPGA) pro-
grammable hardware platform [8]. Through an analog interface
the platform, the heart-on-a-chip is able to interact with a
Boston Scientific pacemaker [9]. In Section 4, we demonstrate
the use of the platform in closed-loop testing. We use Endless-
Loop Tachycardia (ELT) as an example to demonstrate the
necessity of closed-loop testing. ELT is a closed-loop execution
where the pacemaker increases the heart rate inappropriately.
This behavior would not arise during open-loop testing which
serves as a perfect example for the necessity of closed-loop
testing.
In our previous work [6], we manually implemented the
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Fig. 3. (a) Electrical conduction system of the heart (b) A VHM represen-
tation of the conduction system with node and path automata modeling the
conduction pathways.
Refractory
Time
V o
ut
t0 t1 t2
ERP RRPRest Rest
t3
t0
t2
t0
t3
t0 t1
Activation Vout
Heart tissue
Activated
during
ERP
RRP
Rest
(a)
(b)
(c1)
(c2)
(c3)
Fig. 4. (a) Heart tissue responds to external potential changes (b)
Action potential which can be divided into timing periods during
which the tissue responds to external signal differently (c) Different
responses of the heart tissue during each periods
VHM model on a FPGA chip and a pacemaker model on
a microcontroller, and showed several closed-loop behaviors
through a digital interface. This work extends our previous
work in three aspects: (a) the heart model implementation
process is automated, which is a key process in a model-
based design framework; (b) With the analog interface the
testing platform is capable of interacting with a commercial
pacemaker. This makes the platform a suitable tool for black-
box testing and during pacemaker certification process. (c) We
use the platform to demonstrated the necessity of closed-loop
testing by triggering the Endless-Loop Tachycardia (ELT) on
a real pacemaker.
II. VIRTUAL HEART MODEL (VHM)
A. Timing properties of the heart tissue
When the electrical potential outside of a heart muscle
change, a series of ion channel activities will happen on the
membrane of the cell and the heart muscle will contract. The
resulting change of the electrical potential outside the tissue is
referred to as Action Potential. (Fig. 4 (b)) The sudden increase
of the potential is referred to as Depolarization. This potential
change will then depolarize adjacent heart tissue, creating a
activation wave throughout the heart. The time needed for the
potential to reach depolarization threshold is the conduction
delay between tissues. After the depolarization the tissue has to
recover from ion depletion. The timing period before the action
potential drop to resting potential is referred to as Refractory
period and can be divided into Effective Refractory Period
(ERP) and Relative Refractory Period (RRP) (Fig. 4 (b)). The
tissue responds to depolarization wave differently during the
refractory periods. During ERP the depolarization wave is
blocked due to lack of ion. (Fig. 4 (c1)) During RRP the
conduction delay of the tissue is increased due to the increased
slope of the action potential. (Fig. 4 (c2)) Heart tissue with
different refractory and conduction periods form the electrical
conduction system of the heart (Fig. 3(a)) and governs the
coordinated contractions of heart muscle for optimal blood
flow.
Heart tissue can also be depolarized by artificial electrical
signals. Implantable cardiac devices like pacemaker monitor
local electrical activities of the heart by inserting leads into
the heart and deliver electrical pacing to restore normal heart
rhythm.
Node Automaton Path Automaton
Fig. 5. Node Automaton models the blocking properties of electrical
signals and Path automaton models the conduction delays between
Nodes
B. Timing Model of the Heart
The heart can be viewed as a conduction network consists
of conduction paths. In VHM, we use node automata (shown
in Fig. 5 (a)) to model the refractory property of heart tissue. In
each state the node respond to external activation differently.
During ERP the node cannot be activated thus no signal can
conduct through. During RRP the signal will be conducted
through with increased delay. We use path automata (Fig. 5
(b)) to abstract the conduction delay of the heart tissue between
nodes. The path can conduct in both directions (Ante and
Retro) and activate the node on the other end after timer runs
out. The heart is modeled by connecting a set of node and
path automata into a conduction network (Fig. 3(b)). Both
node and path automata are implemented in Simulink and the
different heart conditions modeled were validated by a cardiac
electrophysiologist [6].
III. CLOSED-LOOP TESTING PLATFORM
Unlike open loop testing which delivers recorded signals
to the pacemaker, closed-loop testing interactively interfaces
a heart model (with parameters configured for a set of heart
conditions) and responds to the activity (or lack of) from
the pacemaker. Since the input to the pacemaker changes
in response to pacemaker output, closed-loop testing can
capture pacemaker malfunctions which span multiple input-
output sequences. The overall testing capability of the heart-
on-a-chip platform is shown in Fig. ??, and the hardware
implementation is shown in Fig. 1. The platform includes a
VHM on an FPGA which is able to represent common heart
conditions such as bradycardia, tachycardia, heart block, etc
(for mode details refer to [6]). The parameters of the heart
model can be changed at run-time by either switching among
pre-defined parameter sets, or sending values directly to the
model through a user interface in Matlab. A monitoring system
observes logical interactions between VHM and the pacemaker
and checks them against safety invariants at run-time. In the
following subsections we will introduce each component of
the platform in detail.
A. FPGA Implementation of the Heart
Simulink provides two toolboxes for automated code gen-
eration: the Simulink HDL coder [7] which translate Simulink
models into Hardware Description Language (HDL), and Real-
time Workshop which translate Simulink models into C code.
As the result, there are two options for our VHM model
implementation: the node and path automata can either be
implemented in parallel as hardware on a FPGA, or se-
quentially as software on a micro-controller. In a sequential
implementation of a VHM, the time needed to execute one
iteration is inverse proportional to the number of nodes and
paths. As the number increases for more detailed model,
timing constraints for the node and path automata will be
violated. In hardware implementation of the heart model,
resource consumption increases with the model complexity but
the timing constraints are preserved. In this project we trade
resources for time and implement the heart model on FPGA.
The VHM, as well as the monitoring system, are auto-
matically translated into Verilog using Simulink HDL coder.
Machine-generated code tends to be very conservative, as
the generator will prefer to unambiguously maintain model
semantics over any possible performance optimizations. The
machine-generated code then may implement additional logic
and/or registers that may be unnecessary for the desired com-
putation. In the worst case, the machine-generated code might
implement computations which maybe infeasible on the FPGA,
since the generator does not know the exact specifications of
the underlying hardware. As a result, generated HDL will place
a greater burden on FPGA capacity constraints. The trade-off
with automated code generation is the lack of optimization
that handwritten code will have, but preserves the properties
of the model and save design time. In this project we are not
sacrificing model functionality in order to fit these constraints.
Instead we optimize the models in order to generate more
efficient HDL. In other words, by redesigning the models to
use constructs that we know will synthesize correctly and
efficiently on the FPGA. In the heart model implementation
considered here, the Verilog code generated from a VHM with
19 nodes and 19 paths consumed 13,319 look-up tables (LUTs)
on the DE0-Nano FPGA platform [8], accounting for less than
11% of the available resources. With a Verilog wrapper which
maps the inputs and outputs to general-purpose I/O (GPIO)
pins, FPGA chip is able to send and sense digital events to
and from external pacemaker devices.
B. Analog Interface with the Pacemaker
In order to interact with a commercial pacemaker, an ana-
log interface is needed for signal conditioning. The pacemaker
uses bi-polar leads to both sense and pace the heart. The circuit
diagram is shown in Fig. ??. Our analog interface uses an
optical isolation circuit to separate the pacemaker circuit and
the heart implementation. Signals generated form the heart are
attenuated to the appropriate level to interact wit the Boston
Scientific pacemaker and analog pacing signals are converted
to pacing events received by the heart model.
C. Programmable user interface
An user interface has been developed in Matlab (Fig. ??).
Information such as activations of node automata and require-
ment satisfaction are sent to the front-end through a serial
port. The operator can change VHM parameters at runtime
and safety violations issue notifications.
IV. CLOSED-LOOP TESTING
We briefly describe the basic timing functions of a pace-
maker and a case-study of closed-loop testing of a commercial
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Fig. 6. (a)Virtual loop formed by a timing function of the pacemaker and a conduction pathway in the heart (b) Heart signals with and without pacemaker.
The pacemaker inappropriately increases the ventricular rate [10]
pacemaker. More detailed descriptions of the cases and safety
invariants evaluated are in [10].
A. Basic Timing Cycles for a Dual Chamber Pacemaker
A dual chamber pacemaker senses the electrical activation
of the atria and ventricles with two leads inserted into the right
atrium and ventricle, respectively. The primary function of a
dual chamber pacemaker is to 1) maintain an adequate ven-
tricular rate, 2) maintain the appropriate Atrial-Ventrical delay.
The five basic timing cycles for a dual chamber pacemaker
is shown in Fig. ??. After each sensed (VS) or paced (VP)
ventricular event, the pacemaker will deliver Atrial Pacing
(AP) if no Atrial Sense (AS) event occurs within TAEI. If
no ventricular events has been sensed (VS) with in TAVI after
every sensed (AS) or paced (AP) atrial event, the pacemaker
will deliver ventricular pacing (VP). The pacemaker also has a
Upper Rate Interval (URI) timer to track the interval between
two ventricular events. If the URI period is not finished, the
ventricular pacing (VP) is delivered after the period finishes.
The pacemaker also has Post Ventricular Atrial Refractory
Period (PVARP) and Ventricular Refractory Period (VRP) to
mimic the signal blocking of the heart tissue in order to filter
noise.
B. Endless Loop Tachycardia (ELT)
The pacemaker maintains a maximum interval between an
atrial event (AS, AP) and a ventricular event (VS, VP), which
is equivalent to a virtual conduction pathway between the atria
and the ventricles. Along with the intrinsic A-V conduction
pathway (i.e. heart tissue), the pacemaker in the loop represents
a conduction loop along which electrical signal information
can travel through (Fig. 6(a)). While the normal rhythm of the
heart is the common case, a not so uncommon scenario in the
heart is a Premature Ventricular Contraction (PVC), in which
the ventricles contracts prematurely and spontaineously. In the
closed-loop setting (Fig. 6(b) (a)), when a PVC occurs within
a timing window (shown with Marker 1 in Fig. 6(b)), it will
trigger electrical conduction from the ventricles to the atria
through the intrinsic pathway. The pacemaker registers this
signal as an Atrial Sense (AS) (Marker 2 in Fig. 6(b)). This
AS event triggers VP after TAVI, as if the signal conducts
through the virtual A-V pathway (Marker 3 in Fig. 6(b)).
The VP will trigger another V-A conduction and the signal
is traveling within the loop. Since the cycle of the loop is
faster than intrinsic heart rate, this VP-AS-VP-AS pattern will
persist and inappropriately increase the heart rate, and this
closed-loop pacemaker malfunction is referred to as Endless-
Loop Tachycardia (ELT).
ELT is a closed-loop interaction between the heart and
a dual chamber pacemaker. Without the heart responding to
pacemaker pacing, ELT will not occur and thus cannot be
found during open-loop testing. In open-loop setting (Fig. 6(b)
(b)), assuming the same heart condition, the PVC can also
trigger a V-A conduction (Marker 4 in Fig. 6(b)), which will
reset the intrinsic atrial event. However, without taking into
account the pacemaker pacing, the conduction loop does not
exist and no more V-A conduction will be triggered as in the
closed-loop case (Marker 5 in Fig. 6(b)). By examining the
pacemaker pacing (dashed VP events in Fig. 6(b) (b)) after
feeding the open-loop signal as input to the pacemaker, we
may conclude that the pacemaker is operating correctly, and
miss the opportunity to discover the closed-loop malfunction.
C. Identify ELT Using Our Testing Platform
In our testing platform, the PVC event can be triggered
either randomly by the platform or by user input. When the
interval between the last ventricular event (VS, VP) to the PVC
is longer than the blocking period of ventricular tissue, a V-A
conduction can be triggered thus trigger ELT when connected
to a dual chamber pacemaker. We have successfully triggered
ELT execution within the closed-loop system consists of the
testing platform and a Boston Scientific pacemaker.
V. CONCLUSION
In this paper, we presented Heart-on-a-Chip, a closed-
loop testing platform for interactive testing of implantable
pacemakers. We introduced the automated code generation
of the Virtual Heart Model (VHM) from Simulink model to
HDL code and its implementation on a FPGA-based pro-
cessor. Through an analog interface circuit the heart model
implementation can interact with a commercial pacemaker. The
testing platform is able to represent different heart conditions
for closed-loop testing of implantable pacemaker. We use the
Endless-Loop Tachycardia, which is a clinical closed-loop
pacemaker malfunction that the pacemaker inappropriately
increases heart rate, as case study to show the necessity of
closed-loop testing.
REFERENCES
[1] List of Device Recalls, U.S. Food and Drug Admin., (last visited
Jul. 19, 2010).
[2] K. Sandler, L. Ohrstrom, L. Moy, and R. McVay. Killed by
Code: Software Transparency in Implantable Medical Devices.
Software Freedom Law Center, 2010.
[3] FDA: Guidance for the Content of Premarket Submissions for
Software Contained in Medical Devices, 2005.
[4] M. Pajic, Z. Jiang, O. Sokolsky, I. Lee, and R. Mangharam.
From Verification to Implementation: A Model Translation Tool
and a Pacemaker Case Study. In 18th IEEE RTAS 2012, 2012.
[5] Z. Jiang, M. Pajic, S. Moarref, R. Alur, and R. Mangharam.
Modeling and Verification of a Dual Chamber Implantable
Pacemaker. In 18th TACAS 2012, 2012.
[6] Z. Jiang, M. Pajic, and R. Mangharam. Cyber-Physical Mod-
eling of Implantable Cardiac Medical Devices. Proceedings of
the IEEE, 100:122–137, 2012.
[7] HDL coder - http://www.mathworks.com/products/slhdlcoder/.
[8] DE0-Nano Development and Education Board -
http://www.terasic.com.tw/cgi-bin/page/archive.pl?No=593.
[9] Boston Scientific ALTRUA 60 Pacemaker.
http://www.bostonscientific.com/.
[10] Z. Jiang, M. Pajic, and R. Mangharam. Model-based Closed-
loop Testing of Implantable Pacemakers. In ICCPS’11:
ACM/IEEE 2nd Intl. Conf. on Cyber-Physical Systems, 2011.
